A 24-year-old woman "went into complete shock" when the doctor drew round the curtains and told her what was actually wrong ...

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...

Richardson, has published promising findings from the past seven years of research into a new approach for the treatment of ...